<DOC>
	<DOC>NCT02582086</DOC>
	<brief_summary>The aim of this study is to determine the safety and efficacy of a topical natural health product in comparison to placebo for the treatment of herpes labialis.</brief_summary>
	<brief_title>Study of a New Topical Natural Health Product for the Treatment of Herpes Labialis</brief_title>
	<detailed_description />
	<mesh_term>Herpes Labialis</mesh_term>
	<criteria>Female and male, in good health, 18 years of age or older, With history of recurrent herpes labialis with at least twice a year during the past twentyfour months, Agreeing not to take another treatment against cold sore, nor antiinflammatory, antibiotics and steroids, Cooperating in the study, able to be monitored at each visit, aware of the demands and duration of the controls, thus allowing perfect adherence to the established protocol, Must be willing and able to participate and to provide written informed consent, Female subjects of childbearing potential must have a negative pregnancy test at screening and agree to use a proper contraceptive method during the study. Volunteers who refuse to introduce the product to be tested in its routine, With a history of hypersensitivity to the type of product to be tested (e.g., products that contain essential oil), Who have a history of eczema, topical dermatitis, psoriasis or significant skin anomalies on the areas to be tested, Who suffer from a serious illness or health problem or a critical or progressive disease, Who have taken prescription or over the counter medication that could affect skin characteristics or could bias the study (i.e. antibiotics, antihistamines, antiinflammatoriesâ€¦) within 7 days prior to study beginning, Who have recently acquired or who currently have significant skin pigmentation, who frequent tanning salons or foresee exposure to the sun during the study, Who abuse alcohol, drugs and/or tobacco, Female subjects who are pregnant, breastfeeding or expecting to become pregnant during the study.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>